Veeva Summit Europe: future-proofed AI set to bolster business pharma operations
On the 2025 Veeva Business Summit Europe, trade members touted the present and future potential of AI within the life...
Pharmaceutical Updates
GLP-1 and Alzheimer’s, Eli Lilly, Takeda, FDA: Readout Publication
Wish to keep on prime of the science and politics driving biotech right this moment? Join to get our biotech publication in...
FDA Reversals Ship UniQure, Biohaven, Capricor, Extra Right into a ‘Tailspin’
Final month, uniQure shocked traders and sufferers alike with the announcement that the FDA had modified its tune on the...
Galapagos CEO tightens strategic focus in pursuit of key property
Henry Gosebruch, who assumed his function as Galapagos CEO in Could 2025, spoke with Pharmaceutical Know-how on the sidelines of...
STAT+: Up and down the ladder: The newest comings and goings
Employed somebody new and thrilling? Promoted a rising star? Lastly solved that hard-to-fill spot? Share the information with us, and...
FDA Probing Affected person Loss of life Linked to Takeda’s Enzyme Substitute Remedy
The FDA is investigating adversarial occasions, together with one demise, in a bunch of sufferers who acquired an enzyme alternative...
“Reckless and dangerous”: consultants weigh in on CDC’s autism-vaccine hyperlink stance
The choice to now publicly state a correlation between autism and vaccines undermines the CDC’s longtime place of the opposite....
South Africa urged to problem obligatory license for Gilead’s HIV prevention drug
Affected person advocacy teams have urged the South African authorities to problem a obligatory license for a groundbreaking HIV prevention...
Lilly’s Weight Loss Trio May Prime $100B in Income Because of Oral Possibility
Eli Lilly’s trio of weight problems drugs may attain $101 billion in peak income worldwide, with 17.6 million eligible individuals...
Eco-design: Shaping the way forward for pharma packaging
Pharmaceutical corporations are striving to stability advanced and evolving regulatory calls for, operational effectivity challenges, and environmental duty in an...
STAT+: A revelatory profile of RFK Jr.
You’re studying the net version of D.C. Prognosis, STAT’s twice-weekly publication concerning the politics and coverage of well being and...
J&J, Aiming for $50B in Most cancers Gross sales, Buys Halda for $3B in Money
Johnson & Johnson is plunking down $3.05 billion in money to purchase Halda Therapeutics in a play to beef up...
FDA approves Sarepta’ up to date Elevidys label for DMD
Elevidys has been accepted to be used in ambulatory sufferers aged 4 years and older who've confirmed mutations within the...
Decide to approve settlement with OxyContin maker Purdue and Sackler household
NEW YORK — A federal chapter court docket choose on Friday mentioned he'll approve OxyContin-maker Purdue Pharma’s newest deal to...
BMS Jettisons Coronary Trial for J&J-Partnered Anticoagulant
Bristol Myers Squibb is discontinuing a late-stage research of the investigational drug milvexian for treating acute coronary syndrome, after a...
